4583.T
Chiome Bioscience Inc.
グロース · 医薬品 · 医薬品 · JP
JPY 82.00
+1.23%Year over year
Reported trailing growth
- Revenue
- -24.0%
- EBITDA
- —
- EBIT
- +5.0%
- EPS
- +21.0%
- Free cash flow
- —
- Operating cash flow
- —
Forward estimates
Based on analyst estimates
- Revenue
- —
- EBITDA
- —
- EPS
- —
Three-year CAGR
- Revenue
- -2.0%
- EBITDA
- +5.2%
- EBIT
- +5.0%
- Net income
- +3.7%
- EPS
- +17.5%
- Free cash flow
- —
Reported trailing growth, forward expectations and three-year compound growth rates · Data as of Mar 1, 2026